Helen of Troy (HELE)
(Delayed Data from NSDQ)
$68.04 USD
+1.34 (2.01%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $68.06 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$68.04 USD
+1.34 (2.01%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $68.06 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Clorox (CLX) Beats Q4 Earnings & Sales Estimates, Stock Down
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2020 results reflect gains from the robust demand for disinfecting and cleaning products due to the coronavirus outbreak, and broad-based growth at all segments.
Newell Brands (NWL) Beats Q2 Earnings & Sales Estimates
by Zacks Equity Research
Strength in the Food and Commercial unit and higher demand for certain categories benefit Newell Brands' (NWL) Q2 results. However, it withdraws the 2020 view on COVID-19 impacts.
Colgate (CL) Q2 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 results reflect strength in North America and Hill's segments as well as robust volume growth and pricing across regions.
Procter & Gamble (PG) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results benefited from rising demand for its products, which have been deemed essential items.
Archer Daniels' (ADM) Stock Up on Q2 Earnings & Sales Beat
by Zacks Equity Research
Archer Daniels' (ADM) better-than-expected Q2 results gain from strength in the Nutrition segment.
Service Corporation (SCI) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2020 results reflect higher earnings and sales, courtesy of increased funeral services performed amid the pandemic and solid cost control.
5 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
Investors always look for companies with a high level of profitability regardless of the present market condition.
Boston Beer (SAM) Stock Up on Q2 Earnings Beat, Sales Up Y/Y
by Zacks Equity Research
Boston Beer's (SAM) Q2 results gain from solid depletion growth along with strength in Truly Hard Seltzer and Twisted Tea as well as the Dogfish Head brands.
Corornavirus-Led Store Closures Hurt Inter Parfums' Q2 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales decline year-over-year across all brands and geographies in second-quarter 2020, thanks to coronavirus-led store closures.
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Philip Morris (PM) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2020 results reflect solid pricing variance. However, adverse volume/mix, mainly due to soft cigarette volumes, weighs on revenues and earnings.
Coty's Turnaround Plans Robust, Consumer Beauty Unit Hurts
by Zacks Equity Research
Coty (COTY) is making solid efforts to bring a turnaround to its business. The company's Consumer Beauty segment has been soft for a while.
Zacks.com featured highlights include: Lakeland Industries, Helen of Troy, Turning Point Brands, Esquire Financial, Progress Software and TTEC Holdings
by Zacks Equity Research
Zacks.com featured highlights include: Lakeland Industries, Helen of Troy, Turning Point Brands, Esquire Financial, Progress Software and TTEC Holdings
4 Reasons Why Helen of Troy Appears to be a Lucrative Stock
by Zacks Equity Research
Helen of Troy's (HELE) Health and Home unit has been gaining on rising pandemic-led demand. The company is also gaining from strength in Leadership Brands and solid online business.
6 Top-Rated Stocks That Boast Stellar Net Profit Margins
by Anirudha Bhagat
Let's take a look at these six top-ranked stocks with impressive net profit margins for a winning portfolio.
Estee Lauder's (EL) Robust E-commerce Business Bodes Well
by Zacks Equity Research
Estee Lauder (EL) is benefiting from impressive cost-saving efforts amid the pandemic. The company's robust digital sales are cushioning from the coronavirus outbreak-led store closures.
Helen of Troy (HELE) Shares Gain on Q1 Earnings & Sales Beat
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2021 results reflect higher sales and earnings. Results gain on strength in the Health and Home unit, courtesy of the pandemic-led demand.
Company News for Jul 10, 2020
by Zacks Equity Research
Companies In The News Are: BBBY, WBA, HELE, WFC.
Helen of Troy (HELE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Helen of Troy (HELE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
4 Lucrative Stocks With Amazingly High Net Income Ratio
by Nitish Marwah
Profitability analysis is considered one of the best possible ways to assess the prospects of a company.
Helen of Troy (HELE) Looks Good: Stock Adds 5.1% in Session
by Zacks Equity Research
Helen of Troy (HELE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Helen of Troy's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Helen of Troy.
Philip Morris' (PM) IQOS Gets FDA Nod to be Marketed as MRTP
by Zacks Equity Research
Philip Morris (PM) is likely to benefit from the FDA's latest move. Notably, the FDA authorizes IQOS's marketing as a modified risk tobacco product.
Helen of Troy (HELE) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 61.15% and 13.96%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?
Tech Stocks Continue to Surge Higher
by Jeremy Mullin
The Nasdaq continues to hit highs despite the rise in COVID-19 cases.